Clinical Instrumentation
CT
Computed tomography is a quantitative
imaging technique, developed more than three
decades ago, and has a central role in the study of several diseases in virtually
all areas of medicine.
Using a set consisting of an X-ray emitting source and a ring of detectors rotating
synchronously around the patient, it is possible to calculate the
density of
different tissues
that attenuate radiation.
Moreover, the use of iodinated contrast medium intravenously
allows
to characterize
tissues based on pharmacokinetic properties that depend on circulatory variables
and, especially, in the proportion that each of these tissues are
part of the
the
intracellular, intravascular and extracellular
compartments.
In this
way, the development of helical technology
and devices with multiple
detector rows computed
tomography (MDCT) has been a breakthrough. Not only isotropic
multiplanar images (with equal resolution in all directions)
can
be
obtained,
but
it is possible to
acquire anatomical images of large areas in seconds, minimizing motion artifacts
and allowing multiphase contrast studies,
as well. The latter are particularly suitable
for the characterization of normal and pathological tissues based on their
kinetics of impregnation.
Nevertheless,
the information provided by MDCT is primarily anatomical. This is especially
evident with respect to lymph nodes
for example.
It
is difficult
to determine from available morphological criteria
whether they are
normal or pathological.
However, the anatomical
ability of CT is of tremendous value for nuclear medicine techniques.
Both, for PET and SPECT, during the image reconstruction process, CT X-rays may be used to correct for attenuation of the various radionuclide photons within body tissues. This allows to get their correct concentration and therefore the construction of a more accurate image. The fusion of PET or SPECT images with CT, gives a tremendous advantage in terms of exact localization of areas that concentrate the radiotracers, a weak aspect on nuclear medicine due to limited spatial resolution. More recently and in order to achieve better accuracy, a low dose CT is done first, then follows 18F-FDG PET and finally a contrast-enhanced standard dose CT is performed keeping the highest yield for PET and CT.
In this
sense, benefits
are obtained from
the combined
functional and
morphologic
technique
in terms of
more precise location of areas of increased uptake of
tracers, and at the
same time in absolute concentrations.
References:
1 Levi de Cabrejas, M y Cabrejas RC. Instrumentacion. pp: 19-35. Medicina Nuclear Aplicaciones Clínicas. Eds: I. Carrio - P. González. Editorial Masson, Barcelona España, 2003.
2 Control de calidad de los instrumentos de medicina nuclear. IAEA-TECDOC 602/S, 1996.
3 Eric M. Rohren, Timothy G. Turkington, R. Edward Coleman. Clinical Applications of PET in OncologyRadiology 2004; 231:305–332.
4 Kitajima K, Murakami K, Yamasaki E, Kaji Y, Shimoda M, Kubota K, Suganuma N, Sugimura K. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. Mol Imaging Biol. 2010 Aug;12(4):452-9.
5
Strobel K, Heinrich S, Bhure U, Soyka J, Veit-Haibach P, Pestalozzi BC, Clavien
PA, Hany TF.Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing
the resectability of pancreatic cancer.J Nucl Med. 2008 Sep;49(9):1408-13.
Page 9 Home Index Clinical Nuclear Medicine Therapeutic Methods Previous Page